GUANGZHOU, China, March 02, 2017 -- YY Inc. (NASDAQ:YY) ("YY" or the “Company”), a live streaming platform, today announced that it plans to release its fourth quarter and full year 2016 financial results on Tuesday, March 14, 2017 before market open. The Company will hold a conference call on Tuesday, March 14, 2017 at 8:00 am Eastern Time or 8:00 pm Beijing Time to discuss the financial results. Participants may access the call by dialing the following numbers:
| United States: | +1-845-675-0438 |
| International Toll Free: | +1-855-500-8701 |
| China Domestic: | 400-1200-654 |
| Hong Kong: | +852-3018-6776 |
| Conference ID: | # 80888723 |
The replay will be accessible through March 22, 2017 by dialing the following numbers:
| United States Toll Free: | +1-855-452-5696 |
| International: | +61-2-9003-4211 |
| Conference ID: | # 80888723 |
A live and archived webcast of the conference call will also be available at the Company's investor relations website at http://investors.yy.com/.
About YY Inc.
YY Inc. (“YY” or the “Company”) is a live streaming platform that enables users to interact in live online group activities through voice, text and video. Launched in July 2008, YY Client, the Company’s core product, empowers users to create and organize groups of varying sizes to discover and participate in a wide range of activities, including online music and entertainment, online games, online dating, live game broadcasting and education. YY Inc. was listed on NASDAQ in November 2012 and generated revenues of US$910 million in the fiscal year 2015.
Investor Relations Contact: YY Inc. Yuffie Fu Tel: (+86) 20 8212-0000 Email: [email protected] ICR, Inc. Jessie Fan Tel: (+1) 646 915-1611 Email: [email protected]


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



